Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Arthritis Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Arthritis Other
    Canakinumab Approved in EU for Patients 4 Years and Older With Cryopyrin-Associated Periodic Syndromes - (DGNews)
    Canakinumab Gives Faster, Greater Pain Relief in Refractory Gout Patients: Presented at ACR/ARHP - (DGDispatch)
    Previous Urate-Lowering Therapy Plus Febuxostat Lowers Urate Levels, Number of Flares in Patients With Gout: Presented at ACR/ARHP - (DGDispatch)
    Canakinumab Therapy Shows Promise for Systemic Juvenile Idiopathic Arthritis: Presented at AAP - (DGDispatch)
    New Interleukin-12/23 Monoclonal Antibody Effective Against Moderate to Severe Psoriasis: Presented at EADV - (DGDispatch)

    News archive

     Recent webcasts/CME - Arthritis Other
      Molecular Mechanism of Cardiovascular Disease in Inflammatory Arthritis
      Getting to the Root of Gout and Hyperuricemia: Core Principles in Diagnosis and Management for Rheumatologists
      Ankylosing Spondylitis
      Psoriatic Arthritis
      The Epidemiology of Increased Cardiovascular Death in Inflammatory Arthritis

      Webcasts/CME archive

       Recent cases - Arthritis Other
        Papular Xanthomas and Erosive Arthritis in a 3 Year Old Girl, is This a New MRH Variant?
        Idiopathic Destructive Arthritis of the Shoulder
        Superior Dislocation of the Patella: A Case Report
        Concurrent Reactive Arthritis and Myelitis - A Case Report
        Infectious Arthritis of the Knee Caused by Mycobacterium Terrae: A Case Report

        Cases archive
          




        my personal edition > arthritis other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Arthritis Prevalence in Patients Over 65 Will Double Over a 25 Year Period

        Morbidity and Mortality Weekly Report

        06/06/2003
        By Deanna M. Green


        Cases of arthritis and chronic joint symptoms in people over 65 are projected to double between 2005 and 2030, according to a recent American study.

        Incidence of arthritis and other rheumatic conditions, such as chronic joint symptoms (CJS), is known to increase with age. This puts the elderly at the greatest risk of developing these nonfatal yet disabling conditions.

        Furthermore, given that US adults are living longer due to better management of other chronic diseases and lower mortality from infectious diseases, the population of people over 65 continues to grow; thereby increasing the number of people at risk of developing arthritis.

        Jennifer M. Hootman, PhD, and colleagues at the Centres for Disease Control and Prevention, Atlanta, Georgia, United States, estimated the projected future burden of arthritis or CJS in this group.

        Estimates were made using patient-reported diagnoses of arthritis or CJS obtained from the 2001 Behavioural Risk Factor Surveillance System, a random telephone survey of US adults over the age of 18, and US Census projections of the national population for 2005 to 2030.

        Census reports estimated that the number of US citizens over the age of 65 will increase from 12.9% of the population in 2005 to 20.0% in 2030. Moreover, if current incidence rates within this population are applied, the number of people with arthritis or CJS will double from 21.4 million in 2005 to 41.1 million in 2030.

        In addition, specific predictions using individual state prevalence rates and population projections indicated that Hawaii will have the lowest incidence (34.8%) and Alabama will have the highest incidence (70.3%) of arthritis within this population. This analysis predicts that in 11 states and Puerto Rico about 60% of people over 65 with have arthritis or CJS in 2025.

        Based on these projections, Dr. Hootman recommends that "proven public health interventions should be applied and new interventions developed to improve function, decrease pain, and delay disability among persons with arthritis, particularly those at highest risk for functional impairment and disability."
        Morbidity and Mortality Weekly Report 2003;52:21:489-491.

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send